Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (9712)	6/16/1998 11:19:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

Frost, I think the mms will churn this sucker in the 6's/7's until we get the plant approval. Hopefully our friend from Sweden can keep us updated on news straight from the mouth of Astra. MUSE WILL sell well when in the hands of Janssen and Astra. Vivus should give up the rental force and let the likes of J&J do the PCP footwork for a cut. Just hearing on TV that the Astra/Merck break-up should be announced by tomorrow and that Astra might join up with Bayer. They said that Astra has a weak pipeline and is definitely looking for a merger/buy out. If Astra does have a weak pipeline you can bet that they are going to work hard on MUSE sales since for them it is a new product. This is more good news than most vivus shareholders realize. Also, Pfizer just paid 2.1 billion to buy out a Swiss catheter company called Schneider. If a catheter company can go for a cool 2.1 billion then I'm sure Vivus can easily be swollowed for at least 1/2 billion or less than 1/4 the cost of this catheter company.